{'output': [['Spark Therapeutics', 'ORG', 'Introduce', 'Luxturna', 'PRODUCT'], ['Spark Therapeutics', 'ORG', 'Operate_In', 'Gene Therapy Sector', 'SECTOR'], ['Luxturna', 'PRODUCT', 'Positive_Impact_On', 'Most Patients', 'PERSON'], ['Spark Therapeutics', 'ORG', 'Control', 'Luxturna Price', 'ECON_INDICATOR'], ['Spark Therapeutics', 'ORG', 'Work_With', 'CMS', 'ORG/GOV'], ['Spark Therapeutics', 'ORG', 'Work_With', 'Express Scripts', 'ORG'], ['Spark Therapeutics', 'ORG', 'Sell', 'Luxturna', 'PRODUCT'], ['Express Scripts', 'ORG', 'Own', 'Specialty Pharmacies', 'ORG'], ['Express Scripts', 'ORG', 'Work_With', 'Spark', 'ORG', 'on', 'Refund'], ['Novartis', 'ORG', 'Cover', 'Kymriah', 'PRODUCT'], ['Novartis', 'ORG', 'Based_On', 'Outcomes', 'CONCEPT'], ['Bluebird Bio', 'ORG', 'Expect_To_Submit', 'Beta Thalassemia Treatment', 'PRODUCT'], ['Bluebird Bio', 'ORG', 'Aim_To_Seek_Approval', 'Gene-Based Cancer Therapy', 'PRODUCT'], ['Bluebird Bio', 'ORG', 'Talking_To', 'US Government', 'ORG/GOV'], ['Bluebird Bio', 'ORG', 'Talking_To', 'Governments', 'ORG/GOV', 'in', 'UK', 'GPE', ',', 'France', 'GPE', ',', 'Germany', 'GPE', 'and', 'Italy', 'GPE', 'about', 'Pricing', 'CONCEPT']]}